Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular CarcinomaMakoto Chuma, Shin Maeda, Shuitirou Iwasaki et al.|Cancers|2020Cited by 54
Circulating microRNA‐1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinomaMakoto Chuma, Naoya Sakamoto, Hidenori Toyoda et al.|Hepatology Research|2019Cited by 43
Diagnostic Value of Imaging Methods in the Histological Four Grading of Hepatocellular CarcinomaFeiqian Wang, Shin Maeda, Kazushi Numata et al.|Diagnostics|2020Cited by 22
Radiofrequency Ablation of the Liver: Extended Effect of Transcatheter Arterial Embolization with Iodized Oil and Gelatin Sponge on Histopathologic Changes during Follow-up in a Pig ModelManabu Morimoto, Katsuaki Tanaka, Kazushi Numata et al.|Journal of Vascular and Interventional Radiology|2010Cited by 15
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinomaMakoto Chuma, Shin Maeda, Haruki Uojima et al.|Hepatology International|2024Cited by 11